In a 71-year-old long-term care resident with mild normocytic anemia and a slightly elevated red cell distribution width, what is the most likely cause and what laboratory workup and treatment should be pursued?

Mild Normocytic Anemia with Elevated RDW in Long-Term Care

This 71-year-old long-term care resident most likely has anemia of chronic disease or early nutritional deficiency (iron, B12, or folate), and requires immediate iron studies (ferritin and transferrin saturation), renal function testing (creatinine/eGFR), and reticulocyte count to guide management.

Understanding the Laboratory Findings

The patient presents with:

• Mild normocytic anemia: Hemoglobin 10.6 g/dL (low), MCV 88.4 fL (normal range)
• Elevated RDW: 17.3% (high) - this is the key finding suggesting heterogeneous red cell population
• Normal white blood cell and platelet counts (ruling out multi-lineage bone marrow failure)

The elevated RDW in the context of normocytic anemia is particularly significant. An elevated RDW indicates mixed red cell populations, suggesting either early nutritional deficiency (before MCV changes), combined deficiencies, or active bone marrow response to treatment 1. In elderly patients with cardiometabolic disease, elevated RDW (≥13.5%) is also associated with worse outcomes including frailty 2.

Most Likely Causes in This Population

In long-term care residents aged 70+, the differential diagnosis includes 3, 4:

1. Anemia of chronic disease/inflammation - most common normocytic anemia in hospitalized elderly 5
2. Early or combined nutritional deficiencies (iron, B12, folate) - accounts for majority of cases in elderly 6
3. Chronic kidney disease - increasingly common with age 7
4. Occult blood loss - particularly gastrointestinal 3
5. Myelodysplastic syndrome - though less likely given normal WBC and platelets 1

Essential Initial Workup

Order these tests immediately 3:

Iron Studies (Critical First Step)

• Serum ferritin - most accurate marker for iron stores
• Transferrin saturation - assesses iron available for erythropoiesis
• Rationale: Iron deficiency is the most common treatable cause, and in elderly patients without obvious blood loss, finding iron deficiency mandates GI evaluation for occult bleeding 3

Renal Function

• Creatinine and eGFR - chronic kidney disease is a major cause of normocytic anemia in elderly 3, 8
• Anemia of CKD is normochromic and normocytic, indistinguishable from other chronic conditions 3

Bone Marrow Response Assessment

• Reticulocyte count (with corrected reticulocyte index) - evaluates appropriateness of bone marrow response 3
• Low reticulocyte count suggests inadequate erythropoietin production or inflammation
• High reticulocyte count suggests hemolysis or recent blood loss

Additional Essential Tests

• Vitamin B12 and folate levels - deficiencies common in elderly and long-term care 7, 6
• Inflammatory markers (CRP or ESR) - if anemia of chronic disease suspected
• Peripheral blood smear review - can reveal subtle findings not apparent on automated counts 3

Common Pitfalls to Avoid

Do not dismiss mild anemia in elderly patients as "normal aging" 4, 7. Even mild anemia (hemoglobin 10-12 g/dL) in elderly is associated with:

• Increased mortality and morbidity
• Reduced physical ability and cognitive function
• Decreased quality of life
• Higher hospitalization rates 4

The elevated RDW is not just a curiosity - it provides diagnostic information. In this case, RDW 17.3% suggests either:

• Early nutritional deficiency before MCV changes
• Mixed deficiencies
• Active erythropoiesis in response to treatment or blood loss 1

Do not assume single etiology - 20% of elderly patients have multifactorial anemia 9. You may find combined iron deficiency and chronic kidney disease, or B12 deficiency with inflammation.

Treatment Approach Based on Findings

If Iron Deficiency Identified

• Investigate for GI blood loss (especially if no other obvious source) 3
• Initiate iron supplementation
• Consider IV iron if oral poorly tolerated or malabsorption suspected

If Chronic Kidney Disease Present

• Do not routinely start erythropoiesis-stimulating agents (ESAs) in asymptomatic patients until hemoglobin <10 g/dL 8
• Ensure iron sufficiency before considering ESAs
• Treatment should be individualized based on symptoms and comorbidities

If Nutritional Deficiencies Found

• Replace B12 and/or folate as indicated
• Monitor response with repeat CBC in 4-6 weeks

If Anemia of Chronic Disease

• Focus on treating underlying inflammatory condition 8
• Transfusions only for severe symptomatic anemia
• Consider ESAs only in specific circumstances with documented erythropoietin deficiency

When to Refer to Hematology

Consider hematology consultation if 3:

• Abnormalities in two or more cell lines (WBC, hemoglobin, platelets)
• Anemia remains unexplained after initial workup (occurs in ~17% of cases) 9
• Concern for myelodysplastic syndrome or other bone marrow disorder
• No response to appropriate treatment after 8-12 weeks

Clinical Performance Note

Studies show that diagnostic yield increases significantly as hemoglobin drops further below normal - at 20% below normal range, positive predictive value approaches 100% 9. However, waiting for more severe anemia before investigating is inappropriate given the adverse outcomes associated with even mild anemia in elderly patients 4.